Cytokines in bipolar disorder: paving the way for neuroprogression

doi:10.1155/2014/360481

Review

. 2014:2014:360481.

doi: 10.1155/2014/360481. Epub 2014 Sep 9.

Cytokines in bipolar disorder: paving the way for neuroprogression

Izabela Guimarães Barbosa¹, Moisés Evandro Bauer², Rodrigo Machado-Vieira³, Antonio Lucio Teixeira⁴

Affiliations

¹ Divisão de Neuropsiquiatria, Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Avenida Alfredo Balena, 190 Santa Efigênia, 30130-100 Belo Horizonte, MG, Brazil.
² Laboratório de Imunologia do Envelhecimento, Instituto de Pesquisas Biomédicas, Pontifícia Universidade Católica do Rio Grande do Sul (PUC-RS), 90610-000 Porto Alegre, RS, Brazil.
³ Laboratório de Neurociências, LIM27, Instituto e Departamento de Psiquiatria, Universidade de Sao Paulo, 01060-970 Sao Paulo, SP, Brazil ; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20852, USA.
⁴ Divisão de Neuropsiquiatria, Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Avenida Alfredo Balena, 190 Santa Efigênia, 30130-100 Belo Horizonte, MG, Brazil ; Instituto de Estudos Avançados Transdisciplinares (IEAT), UFMG, 31270-901 Belo Horizonte, MG, Brazil.

PMID: 25313338
PMCID: PMC4172873
DOI: 10.1155/2014/360481

Review

Cytokines in bipolar disorder: paving the way for neuroprogression

Izabela Guimarães Barbosa et al. Neural Plast. 2014.

. 2014:2014:360481.

doi: 10.1155/2014/360481. Epub 2014 Sep 9.

Authors

Izabela Guimarães Barbosa¹, Moisés Evandro Bauer², Rodrigo Machado-Vieira³, Antonio Lucio Teixeira⁴

Affiliations

¹ Divisão de Neuropsiquiatria, Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Avenida Alfredo Balena, 190 Santa Efigênia, 30130-100 Belo Horizonte, MG, Brazil.
² Laboratório de Imunologia do Envelhecimento, Instituto de Pesquisas Biomédicas, Pontifícia Universidade Católica do Rio Grande do Sul (PUC-RS), 90610-000 Porto Alegre, RS, Brazil.
³ Laboratório de Neurociências, LIM27, Instituto e Departamento de Psiquiatria, Universidade de Sao Paulo, 01060-970 Sao Paulo, SP, Brazil ; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20852, USA.
⁴ Divisão de Neuropsiquiatria, Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Avenida Alfredo Balena, 190 Santa Efigênia, 30130-100 Belo Horizonte, MG, Brazil ; Instituto de Estudos Avançados Transdisciplinares (IEAT), UFMG, 31270-901 Belo Horizonte, MG, Brazil.

PMID: 25313338
PMCID: PMC4172873
DOI: 10.1155/2014/360481

Abstract

Bipolar disorder (BD) is a severe, chronic, and recurrent psychiatric illness. It has been associated with high prevalence of medical comorbidities and cognitive impairment. Its neurobiology is not completely understood, but recent evidence has shown a wide range of immune changes. Cytokines are proteins involved in the regulation and the orchestration of the immune response. We performed a review on the involvement of cytokines in BD. We also discuss the cytokines involvement in the neuroprogression of BD. It has been demonstrated that increased expression of cytokines in the central nervous system in postmortem studies is in line with the elevated circulating levels of proinflammatory cytokines in BD patients. The proinflammatory profile and the immune imbalance in BD might be regarded as potential targets to the development of new therapeutic strategies.

PubMed Disclaimer

Cited by

Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.
Felger JC, Treadway MT. Felger JC, et al. Neuropsychopharmacology. 2017 Jan;42(1):216-241. doi: 10.1038/npp.2016.143. Epub 2016 Aug 2. Neuropsychopharmacology. 2017. PMID: 27480574 Free PMC article. Review.
Immune dysregulation in bipolar disorder.
Argue BMR, Casten LG, McCool S, Alrfooh A, Richards JG, Wemmie JA, Magnotta VA, Williams AJ, Michaelson J, Fiedorowicz JG, Scroggins SM, Gaine ME. Argue BMR, et al. J Affect Disord. 2025 Apr 1;374:587-597. doi: 10.1016/j.jad.2025.01.062. Epub 2025 Jan 14. J Affect Disord. 2025. PMID: 39818340
Gestational Diabetes Mellitus Rats Induce Anxiety-Depression-Like Behavior in Offspring: Association with Neuroinflammation and NF-κB Pathway.
Han J, Tan X, Wei Y, Hu Z, Yang Q, Zhu Y, Chen Z, Zhang Y, Yu H, Cai X, Cui S. Han J, et al. Mol Neurobiol. 2025 May 14. doi: 10.1007/s12035-025-05033-x. Online ahead of print. Mol Neurobiol. 2025. PMID: 40360956
Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.
Barichello T, Giridharan VV, Bhatti G, Sayana P, Doifode T, Macedo D, Quevedo J. Barichello T, et al. Curr Top Behav Neurosci. 2021;48:215-237. doi: 10.1007/7854_2020_173. Curr Top Behav Neurosci. 2021. PMID: 33040314
TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder.
Millett CE, Harder J, Locascio JJ, Shanahan M, Santone G, Fichorova RN, Corrigan A, Baecher-Allan C, Burdick KE. Millett CE, et al. Brain Behav Immun. 2020 Aug;88:403-410. doi: 10.1016/j.bbi.2020.04.003. Epub 2020 Apr 6. Brain Behav Immun. 2020. PMID: 32272224 Free PMC article.

See all "Cited by" articles

References

1. Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry. 2011;68(3):241–251. - PMC - PubMed
1. Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H. Recurrence of bipolar disorders and major depression: a life-long perspective. European Archives of Psychiatry and Clinical Neuroscience. 2003;253(5):236–240. - PubMed
1. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry. 2003;60(3):261–269. - PubMed
1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO Press; 2008. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004updat....
1. Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews. 2011;35(3):804–817. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

[1] Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry. 2011;68(3):241–251. - PMC - PubMed

[2] Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry. 2011;68(3):241–251. - PMC - PubMed

[3] Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H. Recurrence of bipolar disorders and major depression: a life-long perspective. European Archives of Psychiatry and Clinical Neuroscience. 2003;253(5):236–240. - PubMed

[4] Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H. Recurrence of bipolar disorders and major depression: a life-long perspective. European Archives of Psychiatry and Clinical Neuroscience. 2003;253(5):236–240. - PubMed

[5] Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry. 2003;60(3):261–269. - PubMed

[6] Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry. 2003;60(3):261–269. - PubMed

[7] World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO Press; 2008. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004updat....

[8] World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO Press; 2008. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004updat....

[9] Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews. 2011;35(3):804–817. - PubMed

[10] Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews. 2011;35(3):804–817. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cytokines in bipolar disorder: paving the way for neuroprogression

Affiliations

Cytokines in bipolar disorder: paving the way for neuroprogression

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical